Abstract
Purpose To describe children with 22q11.2 deletion syndrome functioning from a biopsychosocial perspective, focusing on the impact of children’s health condition from domains to the International Classification of Functioning, Disability and Health (ICF).
Methods A descriptive, cross-sectional case series study with 22q11.2del children. A questionnaire with an ICF checklist for 22q11.2del was completed using a structured interview. The Test of Childhood Language ABFW was used to fill in vocabulary, fluency and language pragmatics questions. The Wechsler Abbreviated Scale of Intelligence (WASI) was used to determine Intelligence Quotient (IQ).
Results Seven participants from 7 to 12 years old, presented some level of IQ impairment. Observed that 22q11.2del children experience significant intellectual, cognitive and speech impairment across ICF Body Function domains. Impairment related to nose and pharynx were found in only one patient. The most relevant categories considered limitations in Activity and Participation component were pertained to producing nonverbal messages, communication, handling stress and social interaction. Family, health professionals and acquaintances were perceived as facilitators in the component Environmental Factors.
Conclusion Children with 22q11.2del have their functioning affected by aspects that go beyond medical diagnosis. A checklist base on ICF for functional profile can contribute to incorporate a biopsychosocial approach.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee from Instituto Fernandes Figueira/ Fiocruz approval was obtained prior to start (n 3.900.914). The work is registered on Plataforma Brazil (CAEE 26957419.6.0000.5269) Participants signed the Free and Informed Term of Commitment in person.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
